{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:56:33Z","timestamp":1792166193470,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Umano Progresso"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This work investigates the role of metabolite levels in the intellectual impairment of subjects with Down syndrome (DS). Homocysteine, folate, vitamin B12, uric acid (UA), creatinine levels and\n                    <jats:italic>MTHFR<\/jats:italic>\n                    C677T genotype were analyzed in 147 subjects with DS. For 77 subjects, metabolite levels were correlated with cognitive tests. Griffiths-III test was administered to 28 subjects (3.08\u20136.16\u00a0years) and WPPSI-III test was administered to 49 subjects (7.08\u201316.08\u00a0years). Significant correlations were found among some metabolite levels and between homocysteine levels and\n                    <jats:italic>MTHFR<\/jats:italic>\n                    C677T genotype. Moreover, homocysteine, UA and creatinine levels resulted increased with age. We did not find any correlation between metabolites and cognitive test score in the younger group. Homocysteine showed statistically significant correlation with WPPSI-III subtest scores when its level is\u2009\u2265\u20097.35\u00a0\u00b5mol\/L, remaining correlated in higher thresholds only for non-verbal area scores. Vitamin B12 showed correlations with all WPPSI-III subtest scores when its level is\u2009&lt;\u2009442\u00a0pg\/mL. The relevance of the present findings is the detection of a specific metabolite threshold related with a better or worse cognitive score, suggesting that vitamin B12 and homocysteine may have a role in cognitive development in children with DS.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-83379-7","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T11:02:53Z","timestamp":1613818973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["One-carbon pathway and cognitive skills in children with Down syndrome"],"prefix":"10.1038","volume":"11","author":[{"given":"Francesca","family":"Antonaros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lanfranchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Olivucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cicchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Carosi Diatricch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Vione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Feliciello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ramacieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Onnivello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Vianello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Pelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Strippoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Cocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pulina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Piovesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Caracausi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"83379_CR1","first-page":"602","volume":"248","author":"J Lejeune","year":"1959","unstructured":"Lejeune, J., Gauthier, M. & Turpin, R. Human chromosomes in tissue cultures. Comptes rendus hebdomadaires des seances de l\u2019Academie des sciences 248, 602\u2013603 (1959).","journal-title":"Comptes rendus hebdomadaires des seances de l'Academie des sciences"},{"key":"83379_CR2","doi-asserted-by":"publisher","first-page":"e797","DOI":"10.1002\/mgg3.797","volume":"7","author":"MC Pelleri","year":"2019","unstructured":"Pelleri, M. C. et al. Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21. Mol. Genet. Genomic Med. 7, e797 (2019).","journal-title":"Mol. Genet. Genomic Med."},{"key":"83379_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fgene.2018.00125","volume":"9","author":"MC Pelleri","year":"2018","unstructured":"Pelleri, M. C. et al. Integrated quantitative transcriptome maps of human trisomy 21 tissues and cells. Front. Genet. 9, 125 (2018).","journal-title":"Front. Genet."},{"key":"83379_CR4","first-page":"1","volume-title":"State of the Art of Research on Down Syndrome","author":"P Strippoli","year":"2019","unstructured":"Strippoli, P. et al. State of the Art of Research on Down Syndrome Vol. 56, 1\u201339 (Academic Press, Cambridge, 2019)."},{"key":"83379_CR5","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1038\/s41598-018-20834-y","volume":"8","author":"M Caracausi","year":"2018","unstructured":"Caracausi, M. et al. Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism. Sci. Rep. 8, 2977 (2018).","journal-title":"Sci. Rep."},{"key":"83379_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41398-019-0578-3","volume":"9","author":"JS Orozco","year":"2019","unstructured":"Orozco, J. S., Hertz-Picciotto, I., Abbeduto, L. & Slupsky, C. M. Metabolomics analysis of children with autism, idiopathic-developmental delays, and Down syndrome. Transl. Psychiatry 9, 243 (2019).","journal-title":"Transl. Psychiatry"},{"key":"83379_CR7","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1111\/febs.15214","volume":"287","author":"C Szabo","year":"2020","unstructured":"Szabo, C. The re-emerging pathophysiological role of the cystathionine-beta-synthase\u2014Hydrogen sulfide system in Down syndrome. FEBS J. 287, 3150 (2020).","journal-title":"FEBS J."},{"key":"83379_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/01.GIM.0000117334.84388.F4","volume":"6","author":"RH Singh","year":"2004","unstructured":"Singh, R. H., Kruger, W. D., Wang, L., Pasquali, M. & Elsas, L. J. Cystathionine beta-synthase deficiency: Effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria. Genet. Med. 6, 90\u201395 (2004).","journal-title":"Genet. Med."},{"key":"83379_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymgme.2014.07.016","volume":"113","author":"V Iacobazzi","year":"2014","unstructured":"Iacobazzi, V., Infantino, V., Castegna, A. & Andria, G. Hyperhomocysteinemia: Related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues. Mol. Genet. Metab. 113, 27\u201333 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"83379_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst, P. et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10, 111\u2013113 (1995).","journal-title":"Nat. Genet."},{"key":"83379_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmg.2014.10.004","volume":"58","author":"SC Liew","year":"2015","unstructured":"Liew, S. C. & Gupta, E. D. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: Epidemiology, metabolism and the associated diseases. Eur. J. Med. Genet. 58, 1\u201310 (2015).","journal-title":"Eur. J. Med. Genet."},{"key":"83379_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cccn.2003.09.016","volume":"340","author":"AC Pereira","year":"2004","unstructured":"Pereira, A. C., Schettert, I. T., Morandini Filho, A. A., Guerra-Shinohara, E. M. & Krieger, J. E. Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population. Clin. Chim. Acta 340, 99\u2013105 (2004).","journal-title":"Clin. Chim. Acta"},{"key":"83379_CR13","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/BF00686245","volume":"25","author":"PM Ueland","year":"1990","unstructured":"Ueland, P. M., Refsum, H. & Christensen, B. Methotrexate sensitivity in Down\u2019s syndrome: A hypothesis. Cancer Chemother. Pharmacol. 25, 384\u2013386 (1990).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"83379_CR14","doi-asserted-by":"publisher","first-page":"15010","DOI":"10.1002\/jcp.28140","volume":"234","author":"L Vitale","year":"2019","unstructured":"Vitale, L. et al. Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate. J. Cell. Physiol. 234, 15010 (2019).","journal-title":"J. Cell. Physiol."},{"key":"83379_CR15","doi-asserted-by":"publisher","first-page":"e12289","DOI":"10.1111\/mcn.12289","volume":"13","author":"MM Murphy","year":"2017","unstructured":"Murphy, M. M., Fernandez-Ballart, J. D., Molloy, A. M. & Canals, J. Moderately elevated maternal homocysteine at preconception is inversely associated with cognitive performance in children 4 months and 6 years after birth. Matern. Child Nutr. 13, e12289 (2017).","journal-title":"Matern. Child Nutr."},{"key":"83379_CR16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12887-019-1716-z","volume":"19","author":"X Sheng","year":"2019","unstructured":"Sheng, X., Wang, J., Li, F., Ouyang, F. & Ma, J. Effects of dietary intervention on vitamin B(12) status and cognitive level of 18-month-old toddlers in high-poverty areas: A cluster-randomized controlled trial. BMC Pediatr. 19, 334 (2019).","journal-title":"BMC Pediatr."},{"key":"83379_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00431-010-1253-0","volume":"169","author":"ME Weijerman","year":"2010","unstructured":"Weijerman, M. E. & de Winter, J. P. Clinical practice. The care of children with Down syndrome. Eur. J. Pediatr. 169, 1445\u20131452 (2010).","journal-title":"Eur. J. Pediatr."},{"key":"83379_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/105381510302500405","volume":"25","author":"A Van Hooste","year":"2003","unstructured":"Van Hooste, A. & Maes, B. Family factors in the early development of children with Down syndrome. J. Early Interv. 25, 296\u2013309 (2003).","journal-title":"J. Early Interv."},{"key":"83379_CR19","unstructured":"Vianello, R. Sindrome di Down. Sviluppo Psicologico e Integrazione dalla Nascita all'et\u00e0 Senile. (Junior, 2006)."},{"key":"83379_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnbeh.2015.00232","volume":"9","author":"JO Edgin","year":"2015","unstructured":"Edgin, J. O., Clark, C. A., Massand, E. & Karmiloff-Smith, A. Building an adaptive brain across development: Targets for neurorehabilitation must begin in infancy. Front. Behav. Neurosci. 9, 1\u201315 (2015).","journal-title":"Front. Behav. Neurosci."},{"key":"83379_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1601-5223.1977.tb01207.x","volume":"86","author":"J Lejeune","year":"1977","unstructured":"Lejeune, J. On the mechanism of mental deficiency in chromosomal diseases. Hereditas 86, 9\u201314 (1977).","journal-title":"Hereditas"},{"key":"83379_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7750(03)27001-4","volume":"27","author":"RS Chapman","year":"2003","unstructured":"Chapman, R. S. Language and communication in individuals with Down syndrome. Lang. Commun. Mental Retard. 27, 1\u201334 (2003).","journal-title":"Lang. Commun. Mental Retard."},{"key":"83379_CR23","first-page":"37","volume":"40","author":"DJ Fidler","year":"2009","unstructured":"Fidler, D. J., Most, D. E. & Philofsky, A. D. The Down syndrome behavioural phenotype: Taking a developmental approach. Res. Pract. 40, 37\u201344 (2009).","journal-title":"Res. Pract."},{"key":"83379_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s10803-009-0906-1","volume":"40","author":"GM Griffith","year":"2010","unstructured":"Griffith, G. M., Hastings, R. P., Nash, S. & Hill, C. Using matched groups to explore child behavior problems and maternal well-being in children with Down syndrome and autism. J. Autism Dev. Disord. 40, 610\u2013619 (2010).","journal-title":"J. Autism Dev. Disord."},{"key":"83379_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1365-2788.2010.01316.x","volume":"54","author":"G van Duijn","year":"2010","unstructured":"van Duijn, G., Dijkxhoorn, Y., Scholte, E. M. & van Berckelaer-Onnes, I. A. The development of adaptive skills in young people with Down syndrome. J. Intellect. Disab. Res. 54, 943\u2013954 (2010).","journal-title":"J. Intellect. Disab. Res."},{"key":"83379_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/1034912980450303","volume":"45","author":"M Crombie","year":"1998","unstructured":"Crombie, M. & Gunn, P. Early intervention, families, and adolescents with Down syndrome. Int. J. Disab. Dev. Educ. 45, 253\u2013281 (1998).","journal-title":"Int. J. Disab. Dev. Educ."},{"key":"83379_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/jnnp.2004.039875","volume":"76","author":"JL Gueant","year":"2005","unstructured":"Gueant, J. L. et al. Homocysteine and related genetic polymorphisms in Down\u2019s syndrome IQ. J. Neurol. Neurosurg. Psychiatry 76, 706\u2013709 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"83379_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1086\/321262","volume":"69","author":"M Pogribna","year":"2001","unstructured":"Pogribna, M. et al. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am. J. Hum. Genet. 69, 88\u201395 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"83379_CR29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.clinbiochem.2010.04.058","volume":"43","author":"NA Meguid","year":"2010","unstructured":"Meguid, N. A. et al. Homocysteine and oxidative stress in Egyptian children with Down syndrome. Clin. Biochem. 43, 963\u2013967 (2010).","journal-title":"Clin. Biochem."},{"key":"83379_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jcma.2016.07.005","volume":"80","author":"J Ni","year":"2017","unstructured":"Ni, J. et al. Association between the MTHFR C677T polymorphism, blood folate and vitamin B12 deficiency, and elevated serum total homocysteine in healthy individuals in Yunnan Province, China. J. Chin. Med. Assoc. 80, 147\u2013153 (2017).","journal-title":"J. Chin. Med. Assoc."},{"key":"83379_CR31","doi-asserted-by":"publisher","first-page":"10491","DOI":"10.1038\/s41598-020-67195-z","volume":"10","author":"F Antonaros","year":"2020","unstructured":"Antonaros, F. et al. Plasma metabolome and cognitive skills in Down syndrome. Sci. Rep. 10, 10491 (2020).","journal-title":"Sci. Rep."},{"key":"83379_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1352\/0895-8017(2004)109<456:VAVWMD>2.0.CO;2","volume":"109","author":"S Lanfranchi","year":"2004","unstructured":"Lanfranchi, S., Cornoldi, C. & Vianello, R. Verbal and visuospatial working memory deficits in children with Down syndrome. Am. J. Ment. Retard. 109, 456\u2013466 (2004).","journal-title":"Am. J. Ment. Retard."},{"key":"83379_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1432-1033.1987.tb13413.x","volume":"168","author":"IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN)","year":"1987","unstructured":"IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and symbols for folic acid and related compounds. Recommendations 1986. Eur. J. Biochem. 168, 251\u2013253 (1987).","journal-title":"Eur. J. Biochem."},{"key":"83379_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000017092","volume":"10","author":"M Lehmann","year":"1999","unstructured":"Lehmann, M., Gottfries, C. G. & Regland, B. Identification of cognitive impairment in the elderly: Homocysteine is an early marker. Dement. Geriatr. Cogn. Disord. 10, 12\u201320 (1999).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"83379_CR35","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1038\/s41436-018-0419-4","volume":"21","author":"MA Almuqbil","year":"2019","unstructured":"Almuqbil, M. A., Waisbren, S. E., Levy, H. L. & Picker, J. D. Revising the psychiatric phenotype of homocystinuria. Genet. Med. 21, 1827\u20131831 (2019).","journal-title":"Genet. Med."},{"key":"83379_CR36","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1373\/clinchem.2015.240515","volume":"61","author":"K Adeli","year":"2015","unstructured":"Adeli, K. et al. Biochemical marker reference values across pediatric, adult, and geriatric ages: Establishment of robust pediatric and adult reference intervals on the basis of the Canadian health measures survey. Clin. Chem. 61, 1049\u20131062 (2015).","journal-title":"Clin. Chem."},{"key":"83379_CR37","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1373\/clinchem.2015.240523","volume":"61","author":"K Adeli","year":"2015","unstructured":"Adeli, K. et al. Complex reference values for endocrine and special chemistry biomarkers across pediatric, adult, and geriatric ages: Establishment of robust pediatric and adult reference intervals on the basis of the Canadian health measures survey. Clin. Chem. 61, 1063\u20131074 (2015).","journal-title":"Clin. Chem."},{"key":"83379_CR38","first-page":"122","volume":"91","author":"CS Pavlov","year":"2019","unstructured":"Pavlov, C. S., Damulin, I. V., Shulpekova, Y. O. & Andreev, E. A. Neurological disorders in vitamin B12 deficiency. Ter. Arkh. 91, 122\u2013129 (2019).","journal-title":"Ter. Arkh."},{"key":"83379_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.13207","volume":"26","author":"CA Calderon-Ospina","year":"2020","unstructured":"Calderon-Ospina, C. A. & Nava-Mesa, M. O. B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci. Ther. 26, 5\u201313 (2020).","journal-title":"CNS Neurosci. Ther."},{"key":"83379_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ymgme.2010.11.166","volume":"102","author":"V Infantino","year":"2011","unstructured":"Infantino, V. et al. Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down\u2019s syndrome. Mol. Genet. Metab. 102, 378\u2013382 (2011).","journal-title":"Mol. Genet. Metab."},{"key":"83379_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13148-019-0787-x","volume":"11","author":"L Haertle","year":"2019","unstructured":"Haertle, L. et al. Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer\u2019s disease-related dysregulation. Clin. Epigenet. 11, 195 (2019).","journal-title":"Clin. Epigenet."},{"key":"83379_CR42","first-page":"2303","volume":"43","author":"A Salvi","year":"2019","unstructured":"Salvi, A. et al. Analysis of a nanoparticleenriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis. Int. J. Mol. Med. 43, 2303\u20132318 (2019).","journal-title":"Int. J. Mol. Med."},{"key":"83379_CR43","doi-asserted-by":"publisher","first-page":"e628","DOI":"10.1002\/mgg3.628","volume":"7","author":"F Antonaros","year":"2019","unstructured":"Antonaros, F. et al. MTHFR C677T polymorphism analysis: A simple, effective restriction enzyme-based method improving previous protocols. Mol. Genet. Genomic Med. 7, e628 (2019).","journal-title":"Mol. Genet. Genomic Med."},{"key":"83379_CR44","first-page":"67","volume-title":"State of the Art of Research on Down Syndrome","year":"2019","unstructured":"Lanfranchi, S. (ed.) State of the Art of Research on Down Syndrome Vol. 56, 67\u201392 (Academic Press, Cambridge, 2019)."},{"key":"83379_CR45","unstructured":"Green, E. et al. Griffiths Scales of Child Development, Third Edition (Griffiths III) (2016)."},{"key":"83379_CR46","doi-asserted-by":"crossref","unstructured":"Wechsler, D. Wechsler Preschool and Primary Scale of Intelligence-Third Edition. WPPSI-III (2002).","DOI":"10.1037\/t15177-000"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83379-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83379-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83379-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T23:07:03Z","timestamp":1670022423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83379-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83379"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83379-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"24 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4225"}}